Showing results (101-110 of 580) with videos related to

Sort By:
Pageof 58
Circulation|June 28, 2006
Vascular biomarkers and surrogates in cardiovascular diseaseJean-Claude Tardif, Therese Heinonen, David Orloff, et al.
Atherosclerosis|September 29, 2006
AGE-BSA decreases ABCG1 expression and reduces macrophage cholesterol efflux to HDLKikuo Isoda, Eduardo J Folco, Koichi Shimizu, et al.
Pharmacology & Therapeutics|May 30, 2020
Cathepsin L-selective inhibitors: A potentially promising treatment for COVID-19 patientsTianxiao Liu, Songyuan Luo, Peter Libby, et al.
European Heart Journal|January 18, 2021
The cardiovascular-dialysis nexus: the transition to dialysis is a treacherous time for the heartKevin Chan, Sharon M Moe, Rajiv Saran, et al.
The Journal of Biological Chemistry|September 6, 2012
Adiponectin induces pro-inflammatory programs in human macrophages and CD4+ T cellsXiang Cheng, Eduardo J Folco, Koichi Shimizu, et al.
European Heart Journal|May 13, 2025
Acute coronary syndromes: mechanisms, challenges, and new opportunitiesSimon Kraler, Christian Mueller, Peter Libby, et al.
American Heart Journal|October 11, 2011
Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)Paul M Ridker, Tom Thuren, Andrew Zalewski, et al.
The American Journal of Pathology|October 29, 2004
Enhanced expression of CD44 variants in human atheroma and abdominal aortic aneurysm: possible role for a feedback loop in endothelial cellsAlexandra Krettek, Galina K Sukhova, Uwe Schönbeck, et al.
Circulation Research|January 4, 2019
Reassessing the Mechanisms of Acute Coronary SyndromesPeter Libby, Gerard Pasterkamp, Filippo Crea, et al.
Circulation Research|June 7, 2014
Inflammation and its resolution as determinants of acute coronary syndromesPeter Libby, Ira Tabas, Gabrielle Fredman, et al.
Pageof 58